(Q93531280)
Statements
Continued administration of GM1 ganglioside is required to maintain recovery from neuroleptic-induced sensorimotor deficits in MPTP-treated mice (English)
F B Weihmuller
M Hadjiconstantinou
J P Bruno
No description defined